These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates. Rueda J, Realpe T, Mejia GI, Zapata E, Rozo JC, Ferro BE, Robledo J. Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965 [Abstract] [Full Text] [Related]
23. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol. Al-Mutairi NM, Ahmad S, Mokaddas E. Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677 [Abstract] [Full Text] [Related]
24. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis. Nam KW, Jang WS, Jyoti MA, Kim S, Lee BE, Song HY. Phytomedicine; 2016 May 15; 23(5):578-82. PubMed ID: 27064017 [Abstract] [Full Text] [Related]
25. Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis. Rasslan O, Hafez SF, Hashem M, Ahmed OI, Faramawy MA, Khater WS, Saleh DA, Mohamed MI, Khalifa MA, Shoukry FA, El-Moghazy EH. Int J Tuberc Lung Dis; 2012 Jul 15; 16(7):941-6. PubMed ID: 22584201 [Abstract] [Full Text] [Related]
26. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB. El-Sayed Zaki M, Goda T. Tuberculosis (Edinb); 2007 Mar 15; 87(2):102-8. PubMed ID: 17035089 [Abstract] [Full Text] [Related]
27. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. Al-Mutairi NM, Ahmad S, Mokaddas E, Eldeen HS, Joseph S. BMC Infect Dis; 2019 Jan 03; 19(1):3. PubMed ID: 30606116 [Abstract] [Full Text] [Related]
28. Nosiheptide Harbors Potent In Vitro and Intracellular Inhbitory Activities against Mycobacterium tuberculosis. Yu X, Zhu R, Geng Z, Kong Y, Wang F, Dong L, Zhao L, Xue Y, Ma X, Huang H. Microbiol Spectr; 2022 Dec 21; 10(6):e0144422. PubMed ID: 36222690 [Abstract] [Full Text] [Related]
31. Design, synthesis, and In vitro antituberculosis activity of 2(5H)-Furanone derivatives. Ngwane AH, Panayides JL, Chouteau F, Macingwana L, Viljoen A, Baker B, Madikane E, de Kock C, Wiesner L, Chibale K, Parkinson CJ, Mmutlane EM, van Helden P, Wiid I. IUBMB Life; 2016 Aug 21; 68(8):612-20. PubMed ID: 27346745 [Abstract] [Full Text] [Related]
32. Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis. Santos NCS, Scodro RBL, de Almeida AL, Baldin VP, Nakamura de Vasconcelos SS, Siqueira VLD, Caleffi-Ferracioli KR, Campanerut-Sá PAZ, Cardoso RF. Tuberculosis (Edinb); 2018 Jul 21; 111():41-44. PubMed ID: 30029913 [Abstract] [Full Text] [Related]
33. Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin. Bergmann JS, Woods GL. Diagn Microbiol Infect Dis; 1997 Jul 21; 28(3):153-6. PubMed ID: 9294706 [Abstract] [Full Text] [Related]
34. Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens. Chumpa N, Kawkitinarong K, Rotcheewaphan S, Sawatpanich A, Petsong S, Tumwasorn S, Suwanpimolkul G. Mol Biol Rep; 2020 Apr 21; 47(4):2501-2508. PubMed ID: 32124172 [Abstract] [Full Text] [Related]
35. [Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates]. Ceyhan İ, Vezir S. Mikrobiyol Bul; 2020 Apr 21; 54(2):211-222. PubMed ID: 32723277 [Abstract] [Full Text] [Related]
36. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy. Vilchèze C, Copeland J, Keiser TL, Weisbrod T, Washington J, Jain P, Malek A, Weinrick B, Jacobs WR. mBio; 2018 May 29; 9(3):. PubMed ID: 29844114 [Abstract] [Full Text] [Related]
37. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK, Kim JH, Kang H, Cho JS, Smego RA. Int J Infect Dis; 2009 Mar 29; 13(2):170-5. PubMed ID: 18768342 [Abstract] [Full Text] [Related]
38. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs. Coban AY, Cihan CC, Bilgin K, Uzun M, Akgunes A, Cetinkaya E, Durupinar B. Int J Tuberc Lung Dis; 2006 Apr 29; 10(4):450-3. PubMed ID: 16602412 [Abstract] [Full Text] [Related]
39. Rapid susceptibility test for Mycobacterium tuberculosis to isoniazid and rifampin with resazurin method in screw-cap tubes. Coban AY, Cekic Cihan C, Bilgin K, Uzun M, Akgunes A, Cetinkaya E, Durupinar B. J Chemother; 2006 Apr 29; 18(2):140-3. PubMed ID: 16736881 [Abstract] [Full Text] [Related]
40. Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa. Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM. BMC Infect Dis; 2012 Dec 22; 12():369. PubMed ID: 23259765 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]